Atlas Trials

Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease

Clinical trial NCT02864407 · COMPLETED

Trial details

NCT number
NCT02864407
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2016-12-19
Primary completion
2021-01-20
Enrollment
3223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.